logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Huabin Hu

department of medical oncology
H指数:19
被引数:1,757

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trial

托瑞帕利木单抗联合或不联合塞来昔布的新辅助PD-1阻断治疗用于错配修复缺陷型或微卫星高度不稳定、局部晚期结直肠癌患者的长期结局（PICC）：一项单中心、平行组、非对照、随机Ⅱ期试验的长期结局

eClinicalMedicine
IF10
2025-09-120
OAAI
Xutao Shen; Yue Cai; Weiwei Li; Lishuo Shi; Jianwei Zhang; Xiaoyu Xie; Zehua Wu; Zhuoxin Zheng; Wuteng Cao; Yanhong Deng; Huabin Hu
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (P1CC): a single-centre, parallel-group, noncomparative, randomised, phase 2 trial
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2022-01-01185
PRE
Hu, Huabin; Kang, Liang; Zhang, Jianwei; Wu, Zehua; Wang, Hui; Huang, Meijin; Lan, Ping; Wu, Xiaojian; Wang, Chao; Cao, Wuteng; Hu, Jiancong; Huang, Yan; Huang, Liang; Wang, Huaiming; Shi, Lishuo; Cai, Yue; Shen, Cailu; Ling, Jiayu; Xie, Xiaoyu; Cai, Yonghua; He, Xiaowen; Dou, Ruoxu; Zhou, Jiaming; Ma, Tenghui; Zhang, Xingwei; Luo, Shuangling; Deng, Weihao; Ling, Li; Liu, Hao; Deng, Yanhong

研究方向

暂未获取到该数据
J
Jianwei Zhang
H 指数:22论文数:171被引数:2,454
Z
Zehua Wu
H 指数:19论文数:101被引数:1,613
Y
Yanhong Deng
H 指数:48论文数:623被引数:9,736
J
Jiayu Ling
H 指数:14论文数:77被引数:1,374
X
Xiaoyu Xie
H 指数:19论文数:139被引数:1,486
J
Jianxia Li
H 指数:18论文数:167被引数:1,385
Y
Yanhong Deng
H 指数:0论文数:2被引数:0
L
Lishuo Shi
H 指数:15论文数:66被引数:1,432
黄
黄晋
H 指数:26论文数:83被引数:1,803
Y
Yue Cai
H 指数:0论文数:2被引数:0